Medifast, Inc.
MED
$13.48
$0.29242.22%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.64M | -7.00M | 2.09M | 7.33M | 29.33M |
| Total Depreciation and Amortization | 13.70M | 12.73M | 12.71M | 3.69M | 13.09M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.11M | 21.32M | 19.42M | 43.08M | 27.71M |
| Change in Net Operating Assets | -16.29M | -6.45M | -9.74M | -14.14M | -9.33M |
| Cash from Operations | 4.15M | 20.60M | 24.48M | 39.95M | 60.80M |
| Capital Expenditure | -6.58M | -7.14M | -7.45M | -6.12M | -6.40M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.34M | -18.66M | -19.07M | -11.71M | -56.09M |
| Cash from Investing | -9.91M | -25.80M | -26.52M | -17.82M | -62.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 36.00K | 119.00K | 119.00K |
| Repurchase of Common Stock | -373.00K | -388.00K | -836.00K | -845.00K | -953.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -196.00K | -199.00K | -715.00K | -18.69M | -36.74M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -569.00K | -587.00K | -1.52M | -19.42M | -37.57M |
| Foreign Exchange rate Adjustments | 4.00K | 32.00K | 47.00K | -150.00K | -128.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.32M | -5.75M | -3.51M | 2.56M | -39.39M |